The global plasma therapy market size is expected to grow from $0.36 billion in 2021 to $0.40 billion in 2022 at a compound annual growth rate (CAGR) of 11.3%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The plasma therapy market is expected to reach $0.61 billion in 2026 at a CAGR of 11.4%.
What is the Global Plasma Therapy Market?
The plasma therapy market consists of revenues generated by the companies that are engaged in selling and manufacturing plasma therapy products and related services. Plasma therapy is a technique where high concentrations of plasma are transfused or injected to patients to facilitate the healing process. Plasma therapy is frequently used for facial rejuvenation, androgenetic alopecia, and wound healing among others.
Get a Sample of the global plasma therapy market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&&type=smp
What drives the Global Plasma Therapy Market?
The rising prevalence of osteoarthritis is expected to drive the plasma therapy market during the forecast period. Platelet-rich plasma (PRP), a type of plasma therapy, is considered a safe and efficient treatment for osteoarthritis. PRP is a concentrated autologous blood growth factor, which is injected on to the joint to provide symptomatic relief by decreasing the inflammation and slows the progression of osteoarthritis. According to the Centres for Disease Control and Prevention (CDC), around 32.5 million people in the USA are suffering from osteoarthritis in 2019. Therefore, an increase in the prevalence of osteoarthritis is expected to drive the plasma therapy market.
Get the full global plasma therapy industry report here:
https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report
Global Plasma Therapy Market Segments
The global plasma therapy market is segmented:
By Type: Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), Leukocyte-Rich Fibrin (L-PRF)
By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair and Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Others
By End-User: Hospitals and Clinics, Laboratories, Research Institutes
By Geography: The regions covered in the plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Plasma Therapy Global Market Report 2022provides market size and growth forecasts for the global plasma therapy market, global plasma therapy market share, plasma therapy market segments and geographies, plasma therapy market competitive landscape including leading competitors’ revenues, profiles and market shares. The plasma therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Plasma Therapy Industry Playersinclude Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex, Inc., Biotest AG, China Biologic Products Holdings, Inc., DePuy Synthes Companies, CSL Limited, Grifols, S.A., Octapharma, and Terumo BCT Inc. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
